YOLFTbeta
Orthopediatrics Corp

Orthopediatrics Corp

KIDS · NASDAQ · Healthcare / Medical Devices

32.35USD-0.23 (-0.71%)

Price History

Full chart

Market Stats

Previous Close32.58
Open32.89
Day Range32.15 – 34.11
52-Week Range14.42 – 26.74
Volume114.27K
Market Cap588.78M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.68
Dividend Yield0.00%
Beta0.98
50-Day Avg22.45
200-Day Avg18.85

About

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. David R. Bailey
  • Employees602
  • Headquarters2850 Frontier Drive, Warsaw, IN, United States, 46582, USA
  • Websitehttps://www.orthopediatrics.com

Leadership

  • Mr. Mark C. ThrodahlExecutive Chairman · b. 1951
  • Mr. David R. BaileyPresident, CEO & Director · b. 1979
  • Mr. Fred L. HiteCFO, Principal Financial & Accounting Officer, COO and Director · b. 1968
  • Mr. Daniel J. Gerritzen J.D.Executive VP of Legal, General Counsel & Secretary · b. 1970
  • Mr. Gregory A. OdlePresident of Scoliosis · b. 1970
  • Mr. Joseph W. HauserPresident of Trauma, Deformity Correction & OPSB · b. 1982
  • Mr. Kevin L. Unger CHE, MBA/MSHAPresident of Enabling Technologies · b. 1972
  • Mr. Mark KarshnerSenior Vice President of International Sales
  • Ray GarrisonSenior Vice President of Quality & Regulatory and Clinical

Financials

Income Statement

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.68M31.00M37.30M45.62M57.56M72.55M71.08M98.05M122.29M148.73M204.73M236.35M
Growth (%)-+30.91%+20.30%+22.31%+26.17%+26.05%-2.03%+37.95%+24.72%+21.62%+37.65%+15.45%
Cost of Revenue7.08M9.37M10.93M11.17M14.88M17.93M16.05M24.65M31.63M37.48M56.13M63.69M
Gross Profit16.60M21.64M26.37M34.45M42.68M54.62M55.03M73.40M90.66M111.25M148.60M172.66M
Gross Margin70.09%69.79%70.69%75.52%74.15%75.28%77.42%74.86%74.14%74.80%72.58%73.05%
Operating Expense23.74M28.23M32.49M40.92M52.23M63.70M81.79M91.43M116.06M138.00M178.12M201.66M
Operating Income-7.14M-6.59M-6.13M-6.47M-9.55M-9.08M-26.75M-18.02M-25.40M-26.75M-29.52M-29.00M
Operating Margin-30.16%-21.26%-16.43%-14.19%-16.60%-12.51%-37.64%-18.38%-20.77%-17.99%-14.42%-12.27%
EBITDA-5.63M-4.77M-3.19M-4.04M-6.88M-4.51M-22.25M-7.19M-8.69M-8.38M-20.23M-11.94M
EBITDA Margin-23.79%-15.38%-8.56%-8.85%-11.95%-6.22%-31.30%-7.34%-7.11%-5.63%-9.88%-5.05%
Net Income-9.55M-7.89M-6.57M-8.93M-12.03M-13.73M-32.94M-16.26M1.26M-20.97M-37.82M-39.65M
Net Income Margin-40.32%-25.45%-17.62%-19.58%-20.89%-18.93%-46.35%-16.58%1.03%-14.10%-18.47%-16.78%
R&D1.68M1.79M2.22M3.42M4.73M5.75M5.27M5.54M8.45M10.89M11.03M9.10M
R&D as % of Total Revenue7.11%5.77%5.96%7.50%8.22%7.92%7.42%5.65%6.91%7.33%5.39%3.85%
Interest Expense2.55M1.23M1.48M2.49M2.25M3.54M3.41M2.25M2.42M198.00K2.62M6.00M
Interest Expense % of Total Revenue10.76%3.97%3.96%5.46%3.92%4.88%4.80%2.29%1.98%0.13%1.28%2.54%

Balance Sheet

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets35.83M30.69M30.68M82.30M112.11M194.56M324.83M308.40M427.73M438.75M473.21M508.63M
Total Liabilities17.85M19.38M24.68M34.81M30.37M52.20M90.06M83.03M49.08M61.72M118.64M162.03M
Total Equity17.98M11.31M5.99M47.49M81.73M142.36M234.77M225.37M378.65M377.02M354.57M346.60M
Cash6.58M3.88M1.61M42.58M60.69M70.78M30.13M9.01M8.99M31.05M43.82M19.56M
Total Debt13.24M13.14M17.54M25.45M21.27M26.25M26.52M28.51M907.00K10.06M80.90M99.99M
Net Debt6.66M9.26M15.93M-17.13M-39.42M-44.52M-3.62M19.50M-8.08M-21.00M37.08M80.43M

Cash Flow

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.92M-892.00K-1.12M-7.22M-15.58M-17.77M-18.53M-13.06M-21.77M-27.05M-27.05M-4.85M
Investing Cash Flow-3.28M-1.71M-4.75M-6.54M-5.96M-61.92M-69.69M-7.41M-113.37M41.68M-13.16M-43.63M
Financing Cash Flow19.72M-98.00K3.60M54.73M39.66M91.02M46.73M6.00K135.97M7.30M53.13M23.98M
Capital Expenditure3.32M2.25M4.75M6.54M5.46M12.09M11.30M16.01M10.03M18.98M14.26M11.11M
Free Cash Flow-13.24M-3.14M-5.87M-13.76M-21.05M-29.86M-29.83M-29.07M-31.80M-46.03M-41.31M-15.96M
Dividends Paid5.96M5.96M5.96M5.96M00------
FCF to OCF133.44%352.47%524.84%190.67%135.06%168.02%160.98%222.57%146.09%170.19%152.73%329.02%
Dividend Paid to FCF-45.05%-189.73%-101.57%-43.35%0.00%0.00%------

Earnings

Report DateAug 10, 2017Nov 8, 2017Mar 7, 2018May 15, 2018Aug 8, 2018Oct 31, 2018Mar 6, 2019May 8, 2019Aug 7, 2019Nov 7, 2019Mar 4, 2020May 5, 2020Aug 6, 2020Nov 4, 2020Mar 10, 2021May 5, 2021Aug 5, 2021Nov 3, 2021Mar 2, 2022May 4, 2022Aug 3, 2022Oct 31, 2022Feb 28, 2023May 1, 2023Jul 31, 2023Nov 6, 2023Mar 5, 2024May 6, 2024Aug 5, 2024Nov 6, 2024Mar 4, 2025May 7, 2025Aug 5, 2025Oct 28, 2025Feb 26, 2026Apr 30, 2026Aug 4, 2026Oct 27, 2026
EPS Estimate0.00-0.12-0.17-0.30-0.15-0.12-0.19-0.17-0.08-0.16-0.22-0.22-0.38-0.31-0.27-0.25-0.33-0.23-0.30-0.37-0.18-0.21-0.25-0.34-0.20-0.20-0.28-0.40-0.26-0.19-0.26-0.43-0.28-0.26-0.37-0.44-0.31-0.25
EPS Actual-0.23-0.13-3.82-0.41-0.21-0.15-0.19-0.21-0.17-0.20-0.29-0.30-0.49-0.19-0.73-0.25-0.11-0.15-0.24-0.30-0.17-0.05-0.35-0.29-0.19-0.13-0.23-0.34-0.23-0.18-0.29-0.39-0.11-0.24-0.26-0.42-0.26-
Surprise--8.33%-2147.06%-36.67%-40.00%-25.00%0.00%-23.53%-112.50%-25.00%-31.82%-36.36%-28.95%38.71%-170.37%0.00%66.67%34.78%20.00%18.92%5.56%76.19%-40.00%14.71%5.00%35.00%17.86%15.00%11.54%5.26%-12.97%9.30%60.71%7.69%29.73%4.55%16.13%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap588.78M
Enterprise Value637.56M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.33
Price / Book1.70
EPS-1.68
Book Value13.16
Revenue (TTM)252.72M
Gross Profit (TTM)186.14M
EBITDA-445.00K
Profit Margin-15.72%
Operating Margin-5.77%
Return on Equity-11.36%
Return on Assets-2.81%
Shares Outstanding26.11M
Shares Float18.22M
Beta0.98
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 7 analystsTarget 27.22
  • Strong Buy
    3
  • Buy
    3
  • Hold
    1

Ownership Breakdown

Institutions
65.89%
Insiders
29.70%
Retail / Other
4.41%

Top Institutional Holders

  • Brown Advisory Holdings Inc
    1.52M5.81%
  • BlackRock Inc
    1.17M4.50%
  • Morgan Stanley - Brokerage Accounts
    1.14M4.37%
  • BRAIDWELL LP
    1.10M4.21%
  • Granahan Investment Management Inc..
    896.74K3.43%
  • Millennium Management LLC
    816.83K3.13%
  • Wellington Management Company LLP
    794.31K3.04%
  • Soleus Capital Management, L.P.
    732.14K2.80%
  • Vanguard Capital Management, LLC
    718.18K2.75%
  • Wasatch Advisors LP
    515.68K1.98%
  • Dimensional Fund Advisors, Inc.
    480.85K1.84%
  • Geode Capital Management, LLC
    432.67K1.66%
  • State Street Corp
    414.04K1.59%
  • The Goldman Sachs Group Inc
    342.44K1.31%
  • Citadel Advisors Llc
    334.65K1.28%
  • Roubaix Capital, LLC
    306.56K1.17%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    534.30K2.05%
  • Wasatch Micro Cap
    511.13K1.96%
  • iShares Russell 2000 ETF
    437.71K1.68%
  • Brown Advisory Small-Cap Growth Inv
    351.13K1.34%